-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Treating MDS Outliers: Patients with Secondary Diseases and Comorbidities

Program: Special-Interest Sessions
Session: ASH/ASCP Summit on Myelodysplastic Syndromes
Saturday, December 5, 2015, 4:00 PM-5:30 PM
W230, Level 2 (Orange County Convention Center)

Rami S. Komrokji, MD

Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL; Malignant Hematology Department, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Disclosures: Komrokji: Novartis: Research Funding , Speakers Bureau ; Celgene: Consultancy , Research Funding ; Pharmacylics: Speakers Bureau ; Incyte: Consultancy .

See more of: ASH/ASCP Summit on Myelodysplastic Syndromes
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation >>